Clinical Trial

Observational Study to Evaluate the Efficacy of OLMETEC Tab on Nocturnal Blood Pressure Control in Patients With Stage Ⅰ Hypertension

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 7, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, multicenter, observational study to evaluate the effectiveness of Olmetec® or Olmetec Plus® on nocturnal blood pressure control in Korean patients with stage 1 hypertension. Patients receiving Olmetec-based therapy in routine clinical practice will be followed to assess changes in ambulatory blood pressure, including nocturnal blood pressure and blood pressure variability.
Trial Details
NCT Number NCT07515599
Lead Sponsor Daewoong Pharmaceutical Co. LTD.
Conditions Stage 1 Hypertension
Enrollment 12,000 participants
Start Date 2025-09-17
Primary Completion 2026-07-31 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-07